Miris (MIR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for Q2 2024 increased by 32% year-over-year to 4,340 tkr, with a 31% rise for H1 2024 to 7,922 tkr.
Result after tax improved by 51% in Q2 2024 to -2,010 tkr, mainly due to higher sales and cost reductions.
Sales of consumables rose 42% in Q2 and 53% in H1 compared to the previous year.
The company completed a rights issue, raising 13.2 Mkr before costs, supporting future operations.
Miris HMA® installations expanded to new markets, including Panama and additional US states.
Financial highlights
Q2 2024 net sales: 4,340 tkr (3,277 tkr in Q2 2023); H1 2024: 7,922 tkr (6,056 tkr in H1 2023).
Q2 2024 result after tax: -2,010 tkr (-3,914 tkr in Q2 2023); H1 2024: -4,963 tkr (-9,304 tkr in H1 2023).
Earnings per share Q2: -0.030 SEK (-0.205); H1: -0.117 SEK (-0.486).
Cash at period end: 1,456 tkr (619 tkr in Q2 2023); net debt/equity ratio: 1.65 (3.09).
Equity at period end: 4,102 tkr (2,450 tkr in Q2 2023); soliditet: 24% (13%).
Outlook and guidance
Management maintains focus on achieving positive cash flow by 2026.
Confirmed sales growth and increased quote requests support expectations for continued market recovery.
Liquidity is expected to be sufficient until the next warrant exercise period in September 2025.
Latest events from Miris
- Q1 2026 sales dropped 25% year-over-year, but a robust order pipeline signals recovery ahead.MIR
Q1 202628 May 2026 - Improved annual results and strong recurring revenue growth, with a solid financial position.MIR
Q4 202511 Feb 2026 - Revenue up 6.4% and net loss narrowed 37% in Q3, with strong liquidity and global demand.MIR
Q3 202527 Nov 2025 - Sales up 21% in H1 2025, losses halved, and liquidity boosted by new capital raises.MIR
Q2 202520 Aug 2025 - First-ever positive monthly result and strong recurring revenue growth mark Miris' Q3 2024.MIR
Q3 202413 Jun 2025 - Q1 sales up 28% and net loss narrows as Miris secures funding for growth toward 2026 profitability.MIR
Q1 20256 Jun 2025 - Revenue up 14% and net loss halved; Miris nears profitability but needs new capital.MIR
Q4 20246 Jun 2025